What is CRISPR doing in medicine right now?

CRISPR-based treatments are approved for sickle cell disease and beta thalassemia, and trials are underway for hereditary blindness, high cholesterol, and some…

CRISPR-based treatments are approved for sickle cell disease and beta thalassemia, and trials are underway for hereditary blindness, high cholesterol, and some cancers. The first approvals took decades of research—most uses are still experimental.

Why CRISPR is different from ordinary medicine

Most medicines manage symptoms or help the body cope with a disease. CRISPR aims at the underlying instructions: the DNA change that causes an inherited condition in the first place. That promise is why the first approved treatments, for sickle cell disease and beta thalassemia, matter so much. The challenge is delivery and safety. Editing cells taken from the body, checked, and returned is very different from editing cells safely inside a living organ, which is why progress is careful and many uses remain experimental.

What to do, step by step

1. When you see a CRISPR headline, first ask whether it describes an approved treatment or an early research trial.
2. Check which condition and which cells are involved, and whether editing happens inside the body or in a laboratory.
3. Look for regulators, hospitals, or peer-reviewed studies as sources instead of relying only on a company announcement.
4. Read the risks and unknowns, including how long patients will be followed to check the edit stays safe.
5. Talk to your own doctor about real options, and never pay an unapproved clinic promising gene-editing cures.